Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
European Commission approval for azacitidine tablets as frontline oral maintenance therapy for adults with acute myeloid leukaemia
European Commission approval for azacitidine tablets as frontline oral maintenance therapy for adults with acute...
Researchers discover a novel class of drugs that may help treat a deadly type of lymphoma
Researchers discover a novel class of drugs that may help treat a deadly type of lymphoma
Medical researchers identify the role of family history in the link between blood lipids and oesophageal cancer
Medical researchers identify the role of family history in the link between blood lipids and oesophageal cancer
Study reveals racial and ethnic disparities in childhood cancers by single year of age
Study reveals racial and ethnic disparities in childhood cancers by single year of age
FDA approves avapritinib for advanced systemic mastocytosis
FDA approves avapritinib for advanced systemic mastocytosis
EHA 2021: First-line ibrutinib + venetoclax is superior to chlorambucil + obinutuzumab for chronic lymphocytic leukaemia/small lymphocyte lymphoma
EHA 2021: First-line ibrutinib + venetoclax is superior to chlorambucil + obinutuzumab for chronic lymphocytic...
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in multiple myeloma patients
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in...
EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in elderly patients with transplant-ineligible newly diagnosed multiple myeloma
EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in elderly...
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
EHA 2021: Clinical trial efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Is mirrored in the real world
EHA 2021: Clinical trial efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Is mirrored in...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation